U

CG Oncology, Inc.

Recommendation
Dividend Power Score
Latest Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)

06/30/2026 03/31/2026 12/31/2025 09/30/2025 06/30/2025
Net Income -75.18% -76.91% -82.87% -108.09% --
Total Depreciation and Amortization 1,370.65% 4,250.00% 4,415.63% 1,555.56% --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 147.72% 141.97% 290.23% 4,494.83% --
Change in Net Operating Assets -89.97% -133.74% -21.68% 1,774.79% --
Cash from Operations -90.23% -95.19% -68.14% -60.66% --
Capital Expenditure -268.07% -77.31% 42.74% -1,244.00% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -140.51% -106.56% 25.56% 53.70% --
Cash from Investing -156.14% -118.72% 18.27% 46.17% --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- 100.00% --
Issuance of Common Stock 142.40% 141.43% -75.65% -31.96% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 108.23% 51.30% 90.77% 95.79% --
Cash from Financing 142.92% 141.58% -75.55% -30.86% --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 147.58% 78.41% -190.26% -94.77% --